A
A
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
3 - Artemis Strategic Investment Corp (0001839990) (Issuer)
PHOENIX, AZ / ACCESSWIRE / September 18, 2023 / Artemis Strategic Investment Corporation (NASDAQ:ARTE), a publicly traded special purpose acquisition company ("Artemis"), today announced the filing of its registration statement on Form S-4 (the "Registration Statement") with the United States Securities and Exchange Commission ("SEC") in connection with Artemis' business combination with Danam Health, Inc. ("Danam"), a health services technology and pharmaceutical distribution company pioneering a healthcare ecosystem model designed to bring efficiency to the prescription journey and promote medication compliance.The Registration Statement contains a preliminary proxy statement and prospectu
Danam Health, Inc. ("Danam") is a health services technology and pharmaceutical distribution company pioneering an ecosystem model designed to empower various stakeholders in the prescription journey and patient medication compliance aspects of healthcare.Founded by a consortium of top-tier pharma executives dedicated to improving the last mile of medication and healthcare delivery, Danam aims to achieve commercial success by utilizing advanced integrative technology to overcome both cost- and geography-related patient access barriers.Danam leverages its proprietary technology to bridge the gap that exists among patients, practitioners, pharmacies, and pharmaceutical product accessibility by
Phoenix, Arizona--(Newsfile Corp. - June 20, 2023) - Artemis Strategic Investment Corporation (NASDAQ:ARTEU) (NASDAQ:ARTE) (NASDAQ:ARTEW) (the "Company") announced today that it had filed a supplement ("Proxy Supplement") to its definitive proxy statement dated June 9, 2023 ("Proxy Statement") for the solicitation of proxies in connection with a special meeting of the Company's stockholders scheduled to be held on June 29, 2023 (the "Extension Meeting"), to consider and vote on, among other proposals, a proposal to extend the date by which the Company must consummate a business combination.The Proxy Supplement discloses that, if the Company's stockholders approve the proposed amendment to th
15-12G - Artemis Strategic Investment Corp (0001839990) (Filer)
25-NSE - Artemis Strategic Investment Corp (0001839990) (Subject)
8-K/A - Artemis Strategic Investment Corp (0001839990) (Filer)
SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)
SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)
SC 13G/A - Artemis Strategic Investment Corp (0001839990) (Subject)